موسسه پزشکی نسل امید
If you are at the pre-marriage stage or before deciding to get pregnant or you are worried about your future pregnancy for any reason, our consultants at hope generation institute are beside you step by step. We carefully check your past medical history and family history. Our genetic counselors check the possibility of repeating risks in your future pregnancy and we will do the required clinical examination step by step to guarantee your future pregnancy health. Our goal is to provide the best services for supporting couples, particularly at-risk ones, to maintain maternal & fetal health. So, we also offer full-skilled specialists and up-to-date high-tech equipment in pre-pregnancy care and genetic services. Our pre-pregnancy services...
Services
If you are at any stage of your pregnancy, we are by your side as one of the leading providers of prenatal care and genetic services for pregnant women. Our clinical services are provided by full-skilled specialists certified by the International Fetal Medicine Foundation (FMF). Our main concern at Hope Generation Institute is maternal and fetal health. So, we use up-to-date four-dimensional ultrasound technology following international standards. Also, if you need invasive (amniocentesis and CVS) and non-invasive (NIPT) diagnostic tests during pregnancy, we provide these services by specialists who have a lot of experience in this field. Our expertise lies within all types of fetal medicine, giving you the best possible healthcare.
Services
We are trying to provide comprehensive professional services for future generation health. By timely diagnosis and treatment of metabolic disorders in newborns, we can significantly prevent future disabilities and more neonatal complications. In this regard, Hope Generation Institute, as known medical institute, has a well-equipped and international standard set up to diagnose and treat congenital metabolic diseases. Also, if your future pregnancy is at-risk for metabolic diseases, you can use our prenatal diagnosis (PGD) service. We provide " newborn hereditary metabolic disorder screening" services in a supportive and reliable environment, with the cooperation of experienced specialists and using the most advanced related technologies
Services
About Image
About Image
shapes
shapes
shapes
about Image

Calculation of gestational age

To calculate the gestational age and possible delivery date, enter the date of the first day of your last menstrual period by day, month and year in the box below.

Service Centers

Services

Genetic counselling services play an essential role in fetal and neonatal health by considering the prevalence risk of disabilities in a family.
Your genetic counsellor considers the possible risk of disease occurrence in which genetics plays an important role. Genetic counselling is a way for people to understand how genetic illnesses can affect them and their family.

Genetic counselling is the first level of our services at Hope Generation Institute. You can find our full-experience genetic counsellors who provide you with online personalized consulting at your "Profile".

Book an appointment today by clicking on the bellow “Request Registration " button.😊

If you are applying for an online reservation at Hope Generation Institute, you can easily enter the relevant page by clicking the bellow "Registration"  button. 

On this page, by filling in Personal Identifiable Information, you can choose the service you want, which is a subset of one of the three centers of Hope Generation Institute. Then, choose your desired date and time from the displayed timetable.
If your information is registered correctly, a “Profile” will be automatically created for you, and the username and password will be sent to you via SMS and email.
Now, you can track all your services from your “Profile”. 


On the other hand, our colleagues will interact with you directly. if your selected service, needs to pay for the final reservation, you should do the electronic payment.
Otherwise, a message will be sent to you:

"Temporary reservation for the selected date and time has been successfully registered“

Please do not forget that the final registration of your time will be done after our colleagues' confirmatory call. So, we will contact you as soon as possible.


Book An Appointment Today …😊

Vice President of Research

Fetal Growth and Development Disorders Research Center

hope plan

This project is carried out in 5 stages and its final goal is to identify the reservoir of mutations of common genetic diseases in the country. In the first phase, 1,500 ...

Gene Therapy and Regenerative Medicine Research Center

Contingent-NIPT Country plan

Recently, a new screening method called NIPT (Cell Free Fetal DNA Testing), which is based on the use of free fetal DNA in the mother's blood circulation, has been introd...

Person-centered medical research center and genometabolomics

National screening plan for hereditary metabolic diseases

hereditary metabolic disorders National Project: Currently, 10 laboratories in IRAN have the ability to perform standard metabolic tests. Hope generation institute passed...

Common Questions

Contingent first-trimester screening for aneuploidies with cell-free DNA in...

The primary aim of this study was to compare the screening performance for trisomy 21 (T21) between combined first-trimester screening (cFTS) with referral for invasive testing at a T21 risk ≥ 1 in 300, and contingent screening consisting of referral for invasive testing at a cFTS-T21 risk ≥ 1 in 100 and referral for cell-free DNA (cfDNA) testing at a cFTS-T21 risk between 1 in 100 and 1 in 1000. Secondary aims were to compare the incidence of fetuses diagnosed with trisomy 18 (T18), trisomy 13 (T13) or sex chromosome aneuploidy, and examine the association between fetal fraction of cfDNA in maternal blood and maternal/fetal characteristics.

The consequences of implementing non‑invasive prenatal testing with cell‑fr...

DNA-based non-invasive prenatal testing (NIPT) using maternal blood constitutes an emerging technology for the detection of Down syndrome (DS). The aim of the study was to conduct a cost-effectiveness analysis to evaluate the economic costs and health implications of the introduction of NIPT based on cell-free fetal DNA analysis through different screening strategies for the detection of DS.

Presenting the results of the National Contingent-NIPT project at the official meeting of the Iran Academy of Medical Sciences

The national plan "determining the use of NIPT test in the screening of chromosomal abnormalities in the first trimester of pregnancy based on the Contingent protocol using the Reflex DNA Testing method" was completed in September 1401. The implementers of the project in line with the advancement of the goals of this national plan and after holding numerous meetings and negotiations and collecting the opinions of professors, experts and health trustees of the country, including Mr. Dr. Malek Afzali, representatives of the Ministry of Health and Medical Education, representatives of forensic medicine and also the country's medical system organization in a meeting that was held on December 21 and hosted by the Academy of Medical Sciences discussed the results of this plan with the professors and scholars of the field. They paid health.

The importance and necessity of holding the placenta and fetus autopsy conference

In this meeting, which was held under the management of Dr. Madbari, the CEO of Hope Generation Medical Institute, specialists and experts from related fields expressed their views regarding the title of this conference. During this meeting, it was suggested to pay attention to the role of fetal autopsy in the diagnosis and management of pregnancies exposed to genetic disorders

Counseling and Genetic Diagnosis of Spinal Muscular Atrophy

This disease is known as one of the most common genetic diseases with autosomal recessive inheritance and also the most common monogenic cause of early infant death. In this disease, the motor neurons of the anterior horn of the spinal cord and the base of the brain (Pons) are depleted and the affected person has difficulty in performing some voluntary movements. The probability of an individual being a carrier for SMA has been reported to be 1 in 25 to 50 in various populations. Studies conducted in our country have reported the number of carriers to be around 1 in 20 people, which is more common than other populations and shows the necessity of screening people in order to identify the carriers of this disease.